Coeptis Therapeutics Holdings, Inc. (COEP)
NASDAQ: COEP · Real-Time Price · USD
0.142
-0.003 (-2.08%)
Dec 20, 2024, 4:00 PM EST - Market closed
COEP Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 |
| Revenue | - | - | - | 0.08 | 0.03 | 0.02 | Upgrade
|
| Revenue Growth (YoY) | - | - | - | 143.82% | 27.68% | -91.49% | Upgrade
|
| Cost of Revenue | - | - | - | - | 0.96 | - | Upgrade
|
| Gross Profit | - | - | - | 0.08 | -0.93 | 0.02 | Upgrade
|
| Selling, General & Admin | 7.8 | 14.82 | 34.18 | 14.12 | 5.78 | 3.05 | Upgrade
|
| Research & Development | 3 | 6.67 | 0.02 | - | 0 | 1.38 | Upgrade
|
| Operating Expenses | 11.26 | 21.49 | 34.2 | 14.12 | 5.78 | 4.43 | Upgrade
|
| Operating Income | -11.26 | -21.49 | -34.2 | -14.05 | -6.71 | -4.41 | Upgrade
|
| Interest Expense | -0.33 | -0.11 | -0.22 | -0.19 | -0.15 | -0.01 | Upgrade
|
| Other Non Operating Income (Expenses) | 0.01 | 0.33 | 0.01 | 0.79 | -2.29 | - | Upgrade
|
| EBT Excluding Unusual Items | -11.58 | -21.27 | -34.41 | -13.45 | -9.16 | -4.42 | Upgrade
|
| Gain (Loss) on Sale of Assets | -0.04 | - | - | -0 | - | 2.31 | Upgrade
|
| Other Unusual Items | - | - | -3.17 | - | - | - | Upgrade
|
| Pretax Income | -11.62 | -21.27 | -37.57 | -13.45 | -9.16 | -2.11 | Upgrade
|
| Net Income | -11.62 | -21.27 | -37.57 | -13.45 | -9.16 | -2.11 | Upgrade
|
| Net Income to Common | -11.62 | -21.27 | -37.57 | -13.45 | -9.16 | -2.11 | Upgrade
|
| Shares Outstanding (Basic) | 37 | 26 | 14 | 11 | 6 | 5 | Upgrade
|
| Shares Outstanding (Diluted) | 37 | 26 | 14 | 11 | 6 | 5 | Upgrade
|
| Shares Change (YoY) | 68.81% | 79.70% | 30.98% | 79.11% | 18.53% | 1.63% | Upgrade
|
| EPS (Basic) | -0.32 | -0.83 | -2.63 | -1.23 | -1.50 | -0.41 | Upgrade
|
| EPS (Diluted) | -0.32 | -0.83 | -2.63 | -1.23 | -1.50 | -0.41 | Upgrade
|
| Free Cash Flow | -6.91 | -7.24 | -3.88 | -4.49 | -3.14 | -3.57 | Upgrade
|
| Free Cash Flow Per Share | -0.19 | -0.28 | -0.27 | -0.41 | -0.51 | -0.69 | Upgrade
|
| Gross Margin | - | - | - | 100.00% | - | 100.00% | Upgrade
|
| Operating Margin | - | - | - | -18727.91% | -21823.77% | -18294.32% | Upgrade
|
| Profit Margin | - | - | - | -17932.37% | -29765.89% | -8741.29% | Upgrade
|
| Free Cash Flow Margin | - | - | - | -5985.92% | -10195.12% | -14800.13% | Upgrade
|
| EBITDA | -10.26 | -20.49 | -33.19 | -13.6 | -6.39 | -4.37 | Upgrade
|
| D&A For EBITDA | 1 | 1 | 1 | 0.45 | 0.32 | 0.03 | Upgrade
|
| EBIT | -11.26 | -21.49 | -34.2 | -14.05 | -6.71 | -4.41 | Upgrade
|
| Revenue as Reported | - | - | - | 0.08 | 0.03 | 0.02 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.